{'fraction_non_alphanumeric': 0.024757804090419805, 'fraction_numerical': 0.010764262648008612, 'mean_word_length': 5.078431372549019, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Antibodies to hepatitis B surface and core antigens in haemophiliacs and their contacts among hospital personnel.

In a group of 65 haemophilia patients one was a chronic carrier of hepatitis B surface antigen (HBsAg) and the remaining 64 patients had antibody to hepatitis B surface antigen (anti-HBs). The antigen carrier and 63 of 64 haemophiliacs with anti-HBs also had antibody to hepatitis B core antigen (anti-HBc). In a second group consisting of 6 younger haemophiliacs, whose treatment with clotting-factor concentrates was started after the initiation of HBsAg tests of all blood products, 3 showed evidence of ongoing or past infection with hepatitis B virus. The prevalences of anti-HBs and anti-HBc among the personnel of the Coagulation Laboratory did not differ from that of the normal population. Anti-HBs was detected by passive haemagglutination and radioimmunoassay, and anti-HBc by immunoelectroosmophoresis.